Form 4 for STAA STAAR SURGICAL CO
Accepted 2023-05-09 00:00:00 ET · period of report 2023-05-08 · accession 0001209191-23-028341 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-05-09 | 2023-05-08 | STAA | Michna Magda | Chief Clinical, Regulatory | M - OptEx | $0.00 | +14.0K | 14.0K | New | $0 |
| D | 2023-05-09 | 2023-05-08 | STAA | Michna Magda | Chief Clinical, Regulatory | M - OptEx | $0.00 | +26.0K | 26.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-05-08 | M | A | 14,047 | $0.00 | 14,047 | D | — | — | (F1) Award of 14,047 Restricted Stock Units of Common Stock (RSU), subject to forfeiture rights, which lapse as to 1/3 of the shares (4682) on 5/08/24, 1/3 of the shares (4682) on 5/08/25, and 1/3 of the shares (4683) on 5/08/26. |
| 2 | Derivative | Common Stock Options | 2023-05-08 | M | A | 25,955 | $0.00 | 25,955 | D | $67.63 · 2024-05-08 to 2033-05-07 | 25,955 Common Stock | (F2) The options granted become exercisable as follows: 1/3 on 5/08/2024 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 5/08/2026. |